Seppo T. Rinne

Seppo T. Rinne

Auto-generated profile, based on publicly available information

Seppo T. Rinne

VA Bedford Healthcare System Center for Health Optimization and Implementation Research Bedford, MA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2018 in Stress and Health
Verified
Journal Article
Closed access
PDF file
KOKristine Olson
Kristine Olson
CSChristine Sinsky
Christine Sinsky
SRSeppo T. Rinne
Seppo T. Rinne
TLTheodore Long
Theodore Long
RVRonald Vender
Ronald Vender
MLMark Linzer
Mark Linzer

17 October 2019 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
VVVarsha G Vimalananda
Varsha G Vimalananda
JOJay D Orlander
Jay D Orlander
MAMelissa K Afable
Melissa K Afable
BFB Graeme Fincke
B Graeme Fincke
ASAmanda K Solch
Amanda K Solch
SSSteven R Simon
Steven R Simon
Objective: Electronic consultations (e-consults) are clinician-to-clinician communications that may obviate face-to-face specialist visits. E-consult programs have spread within the US and internationally despite limited data on outcomes. We conducted a systematic review of the recent peer-reviewed literature on the effect of e-consults on access, cost, quality, and patient and clinician experience and identified the gaps in existing research on these outcomes.Materials and Methods: We searched 4 databases for empirical studies published between 1/1/2015 and 2/28/2019 that reported on one or more outcomes of interest. Two investigators reviewed titles and abstracts. One investigator abstracted information from each relevant article, and another confirmed the abstraction. We applied the GRADE criteria for the strength of evidence for each outcome.Results: We found only modest empirical evidence for effectiveness of e-consults on important outcomes. Most studies are observational and within a single health care system, and comprehensive assessments are lacking. For those outcomes that have been reported, findings are generally positive, with mixed results for clinician experience. These findings reassure but also raise concern for publication bias.Conclusion: Despite stakeholder enthusiasm and encouraging results in the literature to date, more rigorous study designs applied across all outcomes are needed. Policy makers need to know what benefits may be expected in what contexts, so they can define appropriate measures of success and determine how to achieve them.

1 July 2006 in Respiratory Medicine
Verified
Journal Article
Closed access
SRSeppo T. Rinne
Seppo T. Rinne
EREdgar J. Rodas
Edgar J. Rodas
BBBrooke S. Bender
Brooke S. Bender
MRMikael L. Rinne
Mikael L. Rinne
JSJoshua M. Simpson
Joshua M. Simpson
LGLarry T. Glickman
Larry T. Glickman

1 March 2007 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
SRSeppo T. Rinne
Seppo T. Rinne
EREdgar J. Rodas
Edgar J. Rodas
MRMikael L. Rinne
Mikael L. Rinne
JSJoshua M. Simpson
Joshua M. Simpson
LGLarry T. Glickman
Larry T. Glickman
Biomass fuel used for cooking results in widespread exposure to indoor air pollution (IAP), affecting nearly 3 billion people throughout the world. Few studies, however, have tested for an exposure–response relationship between biomass fuel and health outcomes. The aim of this study was to explore the relationship between biomass fuel, infant mortality, and children’s respiratory symptoms. Eighty households in a rural community in Ecuador were selected based on their use of biomass fuel and questioned regarding a history of infant mortality and children’s respiratory symptoms. Carbon monoxide (CO) and particulate matter (PM) were measured in a subset of these homes to confirm the relationship between biomass fuel use and IAP. Results showed a significant trend for higher infant mortality among households that cooked with a greater proportion of biomass fuel (P = 0.008). Similar trends were noted for history of cough (P = 0.02) and earache (P < 0.001) among children living in these households.

24 February 2020 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
SRSeppo T. Rinne
Seppo T. Rinne
DMDavid C. Mohr
David C. Mohr
LSLakshman Swamy
Lakshman Swamy
ABAmanda C. Blok
Amanda C. Blok
EWEdwin S. Wong
Edwin S. Wong
MCMartin P. Charns
Martin P. Charns

3 July 2014 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
SRSeppo T Rinne
Seppo T Rinne
LFLaura C Feemster
Laura C Feemster
BCBridget F Collins
Bridget F Collins
DADavid H Au
David H Au
MPMark Perkins
Mark Perkins
CLChuan-Fen Liu
Chuan-Fen Liu
Thiazolidinediones are oral diabetes medications that selectively activate peroxisome proliferator-activated receptor gamma and have potent anti-inflammatory properties. While a few studies have found improvements in pulmonary function with exposure to thiazolidinediones, there are no studies of their impact on asthma exacerbations. Our objective was to assess whether exposure to thiazolidinediones was associated with a decreased risk of asthma exacerbation.